SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026113
Filing Date
2021-05-10
Accepted
2021-05-10 16:58:20
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 ARCT 10-Q 20210331 arct-10q_20210331.htm   iXBRL 10-Q 1346861
2 EX-31.1 arct-ex311_7.htm EX-31.1 20137
3 EX-31.2 arct-ex312_6.htm EX-31.2 20090
4 EX-32.1 arct-ex321_9.htm EX-32.1 8105
5 EX-32.2 arct-ex322_8.htm EX-32.2 8035
  Complete submission text file 0001564590-21-026113.txt   5139982

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arct-20210331.xsd EX-101.SCH 51653
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20210331_cal.xml EX-101.CAL 40646
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20210331_def.xml EX-101.DEF 146413
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210331_lab.xml EX-101.LAB 349261
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210331_pre.xml EX-101.PRE 263222
11 EXTRACTED XBRL INSTANCE DOCUMENT arct-10q_20210331_htm.xml XML 702159
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 21908114
SIC: 2834 Pharmaceutical Preparations